[1] |
CHEN W,ZHENG R,ZHANG S,et al.Cancer incidence and mortality in China in 2013:an analysis based on urbanization level[J]. Chin J Cancer Res,2017,29(1):1-10.
|
[2] |
TORRE L A,BRAY F,SIEGEL R L,et al.Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87-108.
|
[3] |
ALLEMANI C,MATSUDA T,DI CARLO V,et al.Global surveillance of trends in cancer survival 2000-14 (CONCORD-3):analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet,2018,391(10125):1023-1075.
|
[4] |
NG K K C,CHOK K S H,CHAN A C Y,et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma[J]. Br J Surg,2017,104(13):1775-1784.
|
[5] |
刘永炜,吴向民. 血清AFP、CA199和CEA水平在肝癌诊断和预后中的作用[J]. 检验医学,2017,32(5):406-409.
|
[6] |
PICIOCCHI M,CARDIN R,VITALE A,et al.Circulating free DNA in the progression of liver damage to hepatocellular carcinoma[J]. Hepatol Int,2013,7(4):1050-1057.
|
[7] |
BETTEGOWDA C,SAUSEN M,LEARY R J,et al. Detection of circulating tumor DNA in early- and late-stage human malignancies[J]. Sci Transl Med,2014,6(224):224ra24.
|
[8] |
ONO A,FUJIMOTO A,YAMAMOTO Y,et al.Circulating tumor DNA analysis for liver cancers and its usefulness as a liquid biopsy[J]. Cell Mol Gastroenterol Hepatol,2015,1(5):516-534.
|
[9] |
PARK S,LEE E J,RIM C H,et al.Plasma cell-free DNA as a predictive marker after radiotherapy for hepatocellular carcinoma[J]. Yonsei Med J,2018,59(4):470-479.
|
[10] |
HUANG A,ZHANG X,ZHOU S L,et al.Plasma circulating cell-free DNA integrity as a promising biomarker for diagnosis and surveillance in patients with hepatocellular carcinoma[J]. J Cancer,2016,7(13):1798-1803.
|
[11] |
WEN L,LI J,GUO H,et al.Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients[J]. Cell Res,2015,25(11):1250-1264.
|
[12] |
XU R H,WEI W,KRAWCZYK M,et al.Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma[J]. Nat Mater,2017,16(11):1155-1161.
|
[13] |
GOLDEN R J,CHEN B,LI T,et al.An argonaute phosphorylation cycle promotes microRNA-mediated silencing[J]. Nature,2017,542(7640):197-202.
|
[14] |
BANDOPADHYAY M,SARKAR N,DATTA S,et al.Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis[J]. Infect Agent Cancer,2016,11:40.
|
[15] |
HOPCRAFT S E,AZARM K D,ISRAELOW B,et al.Viral determinants of miR-122-independent hepatitis C virus replication[J]. mSphere,2016,1(1):e00009-e00015.
|
[16] |
ZHU H T,LIU R B,LIANG Y Y,et al.Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma[J]. Liver Int,2017,37(6):888-896.
|
[17] |
ZHOU J,YU L,GAO X,et al.Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma[J]. J Clin Oncol,2011,29(36):4781-4788.
|
[18] |
LI L,CHEN J,CHEN X,et al.Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma[J]. Cancer Letters,2016,373(2):234-240.
|
[19] |
LIN X J,CHONG Y,GUO Z W,et al.A serum microRNA classifier for early detection of hepatocellular carcinoma:a multicentre,retrospective,longitudinal biomarker identification study with a nested case-control study[J]. Lancet Oncol,2015,16(7):804-815.
|
[20] |
OKAJIMA W,KOMATSU S,ICHIKAWA D,et al.Circulating microRNA profiles in plasma:identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function[J]. Oncotarget,2016 ,7(33):53820-53836.
|
[21] |
TOMIMARU Y,EGUCHI H,NAGANO H,et al.Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma[J]. J Hepatol,2012,56(1):167-175.
|
[22] |
ZEKRI A N,YOUSSEF A S E,EL-DESOUKY E D,et al. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection[J]. Tumor Biol,2016,37:12273-12286.
|
[23] |
XU J,LIN H,LI G,et al.The miR-367-3p increases sorafenib chemotherapy efficacy to suppress hepatocellular carcinoma metastasis through altering the androgen receptor signals[J]. EBioMedicine,2016,12:55-67.
|
[24] |
KONISHI H,ICHIKAWA D,YAMAMOTO Y,et al.Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma[J]. Cancer Sci,2016,107(2):149-154.
|
[25] |
ZHENG H,LI P,KWOK J G,et al.Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma[J]. Oncotarget,2017,9(1):224-235.
|
[26] |
LI J,WANG X,TANG J,et al.HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma[J]. Cell Physiol Biochem,2015,37(2):687-696.
|
[27] |
YU J,HAN J,ZHANG J,et al.The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis[J]. Medicine(Baltimore),2016,95(31):e4436.
|
[28] |
JING W,GAO S,ZHU M,et al.Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma[J]. Oncol Rep,2016,36(2):1085-1092.
|
[29] |
ZHANG J,ZHANG D,ZHAO Q,et al.A distinctively expressed long noncoding RNA,RP11-466I1.1,may serve as a prognostic biomarker in hepatocellular carcinoma[J]. Cancer Med,2018. [Epub ahead of print]
|
[30] |
MA Y,LUO T,DONG D,et al.Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma[J]. Gene,2018,663:148-156.
|
[31] |
CHEN C C,CHEN C Y,UENG S H,et al.Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair[J]. Cell Death Dis,2018,9(5):543.
|
[32] |
ZHANG X,ZHOU H,JING W,et al.The circular RNA hsa_circ_0001445 regulates the proliferation and migration of hepatocellular carcinoma and may serve as a diagnostic biomarker[J]. Dis Markers,2018,2018:3073467.
|
[33] |
HAN D,LI J,WANG H,et al.Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression[J]. Hepatology,2017,66(4):1151-1164.
|
[34] |
JOST I,SHALAMOVA L A,GERRESHEIM G K,et al.Functional sequestration of microRNA-122 from hepatitis C virus by circular RNA sponges[J]. RNA Biol,2018,15(8):1032-1039.
|
[35] |
YANG W,DU W W,LI X,et al.Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis[J]. Oncogene,2016,35(30):3919-3931.
|
[36] |
樊绮诗,吴蓓颖. 第二代测序技术在肿瘤诊疗中的应用及其价值与风险[J]. 检验医学,2017,32(4):245-249.
|
[37] |
WANG P,CAO J,LIU S,et al.Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-κB pathway[J]. Oncol Rep,2017,37(5):2883-2890.
|